IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT B IMANI

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1639374747
CMS profile
210562
Location
LANCASTER, CA

General Payments · PY2018–2024

$11,175.07

  • Reported across 370 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,544.00

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,544.00 52

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Otsuka America Pharmaceutical, Inc. $403.57 16
ITI, Inc. $332.79 6
Lundbeck LLC $257.88 13
Takeda Pharmaceuticals U.S.A., Inc. $232.95 8
Axsome Therapeutics, Inc. $125.00 1
ABBVIE INC. $75.72 3
Teva Pharmaceuticals USA, Inc. $44.71 2
Neurocrine BioSciences, Inc. $30.17 1
Supernus Pharmaceuticals, Inc. $22.97 1
Alkermes, Inc. $18.24 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,818.61 44
PY2019 $2,722.41 56
PY2020 $931.55 29
PY2021 $1,148.81 57
PY2022 $1,342.88 68
PY2023 $1,666.81 64
PY2024 $1,544.00 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $25.77 06/05/2024 Food and Beverage Undisputed 01/23/2026 1103966005 CMS
ABBVIE INC. $22.28 10/23/2024 Food and Beverage Undisputed 01/23/2026 1103966007 CMS
ABBVIE INC. $27.67 12/17/2024 Food and Beverage Undisputed 01/23/2026 1103966009 CMS
Alkermes, Inc. $18.24 05/15/2024 Food and Beverage Undisputed 01/23/2026 1120521217 CMS
Axsome Therapeutics, Inc. $125.00 10/30/2024 Food and Beverage Undisputed 01/23/2026 1148316016 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.27 06/28/2024 Food and Beverage Undisputed 01/23/2026 1143246443 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.60 08/14/2024 Food and Beverage Undisputed 01/23/2026 1143246447 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $108.06 10/03/2024 Food and Beverage Undisputed 01/23/2026 1143246451 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $26.67 10/18/2024 Food and Beverage Undisputed 01/23/2026 1143246454 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $145.96 11/07/2024 Food and Beverage Undisputed 01/23/2026 1143246458 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.23 11/14/2024 Food and Beverage Undisputed 01/23/2026 1143246462 CMS
Lundbeck LLC $7.57 03/25/2024 Food and Beverage Undisputed 01/23/2026 1145927482 CMS
Lundbeck LLC $24.92 04/10/2024 Food and Beverage Undisputed 01/23/2026 1145927484 CMS
Lundbeck LLC $25.09 04/17/2024 Food and Beverage Undisputed 01/23/2026 1145927486 CMS
Lundbeck LLC $8.24 05/07/2024 Food and Beverage Undisputed 01/23/2026 1145927488 CMS
Lundbeck LLC $27.96 05/22/2024 Food and Beverage Undisputed 01/23/2026 1145927490 CMS
Lundbeck LLC $10.84 06/11/2024 Food and Beverage Undisputed 01/23/2026 1145927492 CMS
Lundbeck LLC $19.49 07/03/2024 Food and Beverage Undisputed 01/23/2026 1145927494 CMS
Lundbeck LLC $33.30 07/17/2024 Food and Beverage Undisputed 01/23/2026 1145927496 CMS
Lundbeck LLC $9.99 07/23/2024 Food and Beverage Undisputed 01/23/2026 1145927498 CMS
Lundbeck LLC $27.65 08/28/2024 Food and Beverage Undisputed 01/23/2026 1145927500 CMS
Lundbeck LLC $8.37 10/15/2024 Food and Beverage Undisputed 01/23/2026 1145927502 CMS
Lundbeck LLC $25.04 10/16/2024 Food and Beverage Undisputed 01/23/2026 1145927504 CMS
Lundbeck LLC $29.42 11/12/2024 Food and Beverage Undisputed 01/23/2026 1145927506 CMS
Neurocrine Biosciences, Inc. $30.17 05/29/2024 Food and Beverage Undisputed 01/23/2026 1150825622 CMS
Otsuka America Pharmaceutical, Inc. $18.69 01/03/2024 Food and Beverage Undisputed 01/23/2026 1118912149 CMS
Otsuka America Pharmaceutical, Inc. $25.17 01/29/2024 Food and Beverage Undisputed 01/23/2026 1118912151 CMS
Otsuka America Pharmaceutical, Inc. $13.92 02/27/2024 Food and Beverage Undisputed 01/23/2026 1118912153 CMS
Otsuka America Pharmaceutical, Inc. $26.73 02/28/2024 Food and Beverage Undisputed 01/23/2026 1118912155 CMS
Otsuka America Pharmaceutical, Inc. $12.42 04/09/2024 Food and Beverage Undisputed 01/23/2026 1118912157 CMS
Otsuka America Pharmaceutical, Inc. $123.15 04/17/2024 Food and Beverage Undisputed 01/23/2026 1118912159 CMS
Otsuka America Pharmaceutical, Inc. $8.60 04/23/2024 Food and Beverage Undisputed 01/23/2026 1118912161 CMS
Otsuka America Pharmaceutical, Inc. $10.34 04/30/2024 Food and Beverage Undisputed 01/23/2026 1118912163 CMS
Otsuka America Pharmaceutical, Inc. $21.09 05/08/2024 Food and Beverage Undisputed 01/23/2026 1118912165 CMS
Otsuka America Pharmaceutical, Inc. $15.94 08/21/2024 Food and Beverage Undisputed 01/23/2026 1118912167 CMS
Otsuka America Pharmaceutical, Inc. $3.39 09/16/2024 Food and Beverage Undisputed 01/23/2026 1118912169 CMS
Otsuka America Pharmaceutical, Inc. $24.37 09/16/2024 Food and Beverage Undisputed 01/23/2026 1118912171 CMS
Otsuka America Pharmaceutical, Inc. $26.33 10/02/2024 Food and Beverage Undisputed 01/23/2026 1118912173 CMS
Otsuka America Pharmaceutical, Inc. $17.91 10/21/2024 Food and Beverage Undisputed 01/23/2026 1118912175 CMS
Otsuka America Pharmaceutical, Inc. $29.07 11/01/2024 Food and Beverage Undisputed 01/23/2026 1118912177 CMS
Otsuka America Pharmaceutical, Inc. $26.45 12/02/2024 Food and Beverage Undisputed 01/23/2026 1118912179 CMS
Supernus Pharmaceuticals, Inc. $22.97 07/03/2024 Food and Beverage Undisputed 01/23/2026 1147886954 CMS
Takeda Pharmaceuticals U.S.A., Inc. $31.53 01/24/2024 Food and Beverage Undisputed 01/23/2026 1137583770 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.45 02/14/2024 Food and Beverage Undisputed 01/23/2026 1137583774 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.78 04/24/2024 Food and Beverage Undisputed 01/23/2026 1137583778 CMS
Takeda Pharmaceuticals U.S.A., Inc. $34.00 05/15/2024 Food and Beverage Undisputed 01/23/2026 1137583782 CMS
Takeda Pharmaceuticals U.S.A., Inc. $32.35 06/12/2024 Food and Beverage Undisputed 01/23/2026 1137583785 CMS
Takeda Pharmaceuticals U.S.A., Inc. $28.53 07/31/2024 Food and Beverage Undisputed 01/23/2026 1137583788 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.02 09/04/2024 Food and Beverage Undisputed 01/23/2026 1137583792 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.29 11/20/2024 Food and Beverage Undisputed 01/23/2026 1137583795 CMS
Teva Pharmaceuticals USA, Inc. $20.30 02/07/2024 Food and Beverage Undisputed 01/23/2026 1151688359 CMS
Teva Pharmaceuticals USA, Inc. $24.41 03/06/2024 Food and Beverage Undisputed 01/23/2026 1151688400 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.